Global Neurotech Devices Market, By Product Type (Neurostimulation, Deep brain stimulator, Gastric electric stimulator, Spinal cord stimulator, Sacral nerve stimulator, Vagus nerve stimulator, Transcutaneous electrical nerve stimulation, Other neurostimul

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	174 Pages	Coherent Market Insights	March, 2025	CMI19905141

Best Price Guarantee
Price	from $4,500
Length	174 Pages
Publisher	Coherent Market Insights
Published Date	March, 2025
SKU	CMI19905141

Neurotech devices aim to treat a variety of neurological disorders by interfacing directly with the nervous system. These innovative technologies utilize implantable or wearable sensors and stimulating devices to collect neural data and potentially repair damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. The global neurotech devices market is still at a nascent stage but growing rapidly as new products enter clinical trials. Advanced materials and miniaturization of electronics have enabled the creation of biocompatible neural interfaces. Rising public awareness about neurological illnesses and growing government support for neuroscience research are some of the key factors anticipated to drive continued expansion of this market in the coming years.

Market Dynamics:

The neurotech devices market is driven by the rising global prevalence of neurological disorders, technological advancements in neural interfaces, growing demand for minimally invasive therapies, and increasing government funding for neuroscience research. However, factors such as high costs associated with clinical trials and product development, reimbursement challenges for new technologies, and biosafety concerns pertaining to long term device implantation pose significant challenges to market growth. Various startups and large companies have also started exploring applications of neurotech beyond therapeutics, in areas like augmented cognition, which presents lucrative commercial opportunities. Collaborations between researchers, medical device firms, and computing companies are likely to further accelerate the development of next-generation neurotech solutions.

Key features of the study:

This report provides an in-depth analysis of the global neurotech devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global neurotech devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, and Advanced Bionics AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global neurotech devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurotech devices market.

Detailed Segmentation:

Global Neurotech Devices Market, By Product Type
Neurostimulation
Deep brain stimulator
Gastric electric stimulator
Spinal cord stimulator
Sacral nerve stimulator
Vagus nerve stimulator
Transcutaneous electrical nerve stimulation (TENS)
Other neurostimulations
Neuroprostheses
Neurosensing
Neurorehabilitation devices
Global Neurotech Devices Market, By Conditions
Pain management
Cognitive disorders
Epilepsy
Urinary and fecal incontinence
Hearing conditions
Parkinson’s disease
Depression
Sleep disorders
Essential tremor
Other conditions
Global Neurotech Devices Market, By End User
Hospitals
Ambulatory surgical centers
Homecare facilities
Other end users
Global Neurotech Devices Market, By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
Boston Scientific Corporation
BrainCo, Inc
Cochlear Limited
Control Bionics, Inc
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
Natus medical Incorporated
Integra LifeSciences
Blackrock Microsystems
NeuroSigma, Inc.
NeuroVigil Inc.
Neuralink Corp.
Abbott Laboratories
Advanced Bionics AG

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Product Type; Market Snippet, By Conditions; Market Snippet, By End User; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rising incidence of neurological disorders; Integration of AI & IoT in neurotech devices; High cost of neurotech devices; Key Highlights; Regulatory Scenario; Recent Trends; PEST Analysis; PORTER’s Analysis; Product Launches; Mergers, Acquisitions, and Collaborations
4. Global Neurotech Devices Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Neurotech Devices Market, By Product Type, 2020-2032, (US$ Bn): Introduction; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Neurostimulation; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Neurostimulation; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Deep brain stimulator; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Gastric electric stimulator; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Spinal cord stimulator; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Sacral nerve stimulator; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Vagus nerve stimulator; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Transcutaneous electrical nerve stimulation (TENS); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Other neurostimulations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Neuroprostheses; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Neurosensing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Neurorehabilitation devices; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Neurotech Devices Market, By Conditions, 2020-2032, (US$ Bn): Introduction; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Pain management; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Cognitive disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Epilepsy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Urinary and fecal incontinence; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Hearing conditions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Parkinson’s disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Depression; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Sleep disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Essential tremor; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Other conditions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Neurotech Devices Market, By End User, 2020-2032, (US$ Bn): Introduction; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Ambulatory surgical centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Homecare facilities; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn); Other end users; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Neurotech Devices Market, By Region, 2020-2032, (US$ Bn): Introduction; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Region, 2021 – 2032; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn); U.S.; Canada; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn); Germany; U.K.; Spain; France; Italy; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn); Brazil; Argentina; Mexico; Rest of Latin America; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn); GCC Countries; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$; Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn); North Africa; Central Africa; South Africa
9. Competitive Landscape: Company Profile; Boston Scientific Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; BrainCo, Inc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Cochlear Limited; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Control Bionics, Inc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; LivaNova PLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Medtronic plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Nihon Kohden Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Natus medical Incorporated; Integra LifeSciences; Blackrock Microsystems; NeuroSigma, Inc.; NeuroVigil Inc.; Neuralink Corp.; Abbott Laboratories; Advanced Bionics AG; Analyst Views
10. Section: References; Research Methodology; About us; *Browse 35 market data tables and 48 figures on “Global Neurotech Devices Market” - Global forecast to 2032